Aging and cancer

Keyphrases

Publications

volume 5, number 1-2, 2024

Gena M Dominique, Catherine Hammond, M Sharon Stack
The Gut Microbiome in Aging and Ovarian Cancer. Aging and cancer 5 (1-2) (2024)
Gena M Dominique, Catherine Hammond, M Sharon Stack
The Gut Microbiome in Aging and Ovarian Cancer. Aging and cancer 5 (1-2) (2024)
Gena M Dominique, Catherine Hammond, M Sharon Stack
The Gut Microbiome in Aging and Ovarian Cancer. Aging and cancer 5 (1-2) (2024)

volume 4, number 2, 2023

Danting Yang, Meghann Wheeler, Shama D Karanth, Livingstone Aduse-Poku, Christiaan Leeuwenburgh, Stephen Anton, Yi Guo, Jiang Bian, Muxuan Liang, Hyung-Suk Yoon, Tomi Akinyemiju, Dejana Braithwaite, Dongyu Zhang
Allostatic load and risk of all-cause, cancer-specific, and cardiovascular mortality in older cancer survivors: an analysis of the National Health and Nutrition Examination Survey 1999-2010. Aging and cancer 4 (2) (2023)

volume 3, number 1, 2022

Aaron L Sarver, Kelly M Makielski, Taylor A DePauw, Ashley J Schulte, Jaime F Modiano
Increased risk of cancer in dogs and humans: a consequence of recent extension of lifespan beyond evolutionarily-determined limitations? Aging and cancer 3 (1) (2022)
Myrna G Garcia, Yilun Deng, Clare Murray, Ryan Michael Reyes, Alvaro Padron, Haiyan Bai, Aravind Kancharla, Harshita Gupta, Shai Shen-Orr, Tyler J Curiel
Immune checkpoint expression and relationships to anti-PD-L1 immune checkpoint blockade cancer immunotherapy efficacy in aged versus young mice. Aging and cancer 3 (1) (2022)
Myrna G Garcia, Yilun Deng, Clare Murray, Ryan Michael Reyes, Alvaro Padron, Haiyan Bai, Aravind Kancharla, Harshita Gupta, Shai Shen-Orr, Tyler J Curiel
Immune checkpoint expression and relationships to anti-PD-L1 immune checkpoint blockade cancer immunotherapy efficacy in aged versus young mice. Aging and cancer 3 (1) (2022)

volume 3, number 2, 2022

Dejana Braithwaite, Stephen Anton, Supriya Mohile, James DeGregori, Nancy Gillis, Daohong Zhou, Shirley Bloodworth, Marco Pahor, Jonathan Licht
Cancer and aging: A call to action. Aging and cancer 3 (2) (2022)
Elizabeth I Harper, Tyvette S Hilliard, Emma F Sheedy, Preston Carey, Paul Wilkinson, Michael D Siroky, Jing Yang, Elizabeth Agadi, Annemarie K Leonard, Ethan Low, Yueying Liu, Arya Biragyn, Christina M Annunziata, M Sharon Stack
Another Wrinkle with Age: Aged Collagen and Intra-peritoneal Metastasis of Ovarian Cancer. Aging and cancer 3 (2) (2022)
Elizabeth R Kessler, Sarah J Schmiege, Megan Eguchi, Sarguni Singh, Stacy M Fischer
Patterns of treatment in older patients with newly diagnosed advanced bladder cancer: A SEER dataset analysis. Aging and cancer 3 (2) (2022)
Elizabeth R Kessler, Sarah J Schmiege, Megan Eguchi, Sarguni Singh, Stacy M Fischer
Patterns of treatment in older patients with newly diagnosed advanced bladder cancer: A SEER dataset analysis. Aging and cancer 3 (2) (2022)

volume 3, number 3-4, 2022

Ningzhen Fu, Yu Jiang, Zhiwei Xu, Meng Yang, Chenghong Peng, Xiaxing Deng, Shulin Zhao, Baiyong Shen
The impact of Omicron pandemic and COVID-19 vaccination on the pancreatic adenocarcinoma patients. Aging and cancer 3 (3-4) (2022)
Ningzhen Fu, Yu Jiang, Zhiwei Xu, Meng Yang, Chenghong Peng, Xiaxing Deng, Shulin Zhao, Baiyong Shen
The impact of Omicron pandemic and COVID-19 vaccination on the pancreatic adenocarcinoma patients. Aging and cancer 3 (3-4) (2022)

volume 2, number 1-2, 2021

Chelsea G Goodenough, Robyn E Partin, Kristen K Ness
Skeletal Muscle and Childhood Cancer: Where are we now and where we go from here. Aging and cancer 2 (1-2) (2021)
Zachary S Clayton, David A Hutton, Sophia A Mahoney, Douglas R Seals
Anthracycline chemotherapy-mediated vascular dysfunction as a model of accelerated vascular aging. Aging and cancer 2 (1-2) (2021)

volume 2, number 3, 2021

Edward J Evans, James DeGregori
Cells with Cancer-associated Mutations Overtake Our Tissues as We Age. Aging and cancer 2 (3) (2021)
Edmund Charles Jenkins, Mrittika Chattopadhyay, Doris Germain
Are the estrogen receptor and SIRT3 axes of the mitochondrial UPR key regulators of breast cancer sub-type determination according to age? Aging and cancer 2 (3) (2021)

volume 2, number 4, 2021

Matthew D Wogksch, Chelsea G Goodenough, Emily R Finch, Robyn E Partin, Kirsten K Ness
Physical activity and fitness in childhood cancer survivors: a scoping review. Aging and cancer 2 (4) (2021)
Amanda J Audesse, Galina Karashchuk, Zachary A Gardell, Nelli S Lakis, Sun Y Maybury-Lewis, Abigail K Brown, Dena S Leeman, Yee Voan Teo, Nicola Neretti, Douglas C Anthony, Alexander S Brodsky, Ashley E Webb
FOXO3 regulates a common genomic program in aging and glioblastoma stem cells. Aging and cancer 2 (4) (2021)

volume 1, number 1-4, 2020

Tara Fresques, Mark A LaBarge
<PE-AT>Contributions of Yap and Taz dysfunction to breast cancer initiation, progression, and aging-related susceptibility. Aging and cancer 1 (1-4) (2020)
Jason E Galloway, Andrea M Holderbaum, Namrata Arya, Suohui Zhang, Michael S Bodnar, Ruthann Norman, William E Carson, Lianbo Yu, Kari L Kendra, Christin E Burd
Impact of age-related T cell dynamics on the identification of biomarkers predictive of immunotherapy discontinuation: a prospective cohort study. Aging and cancer 1 (1-4) (2020)
Gloria E Marino, Ashani T Weeraratna
A glitch in the matrix: Age-dependent changes in the extracellular matrix facilitate common sites of metastasis. Aging and cancer 1 (1-4) (2020)
Jamie A G Hamilton, Curtis J Henry
Aging and immunotherapies: New horizons for the golden ages. Aging and cancer 1 (1-4) (2020)